Resolutions and Decisions

This page includes a list of Resolutions and Decisions relevant to synthetic drugs, recently adopted at the UN General Assembly (GA), the Economic and Social Council (ECOSOC) or the Commission on Narcotic Drugs (CND).

  • CND Resolution 58/3 (2015)
    Promoting the protection of children and young people, with particular reference to the illicit sale and purchase of internationally or nationally controlled substances and of new psychoactive substances via the Internet

  • CND Resolution 58/7 (2015)
    Strengthening cooperation with the scientific community, including academia, and promoting scientific research in drug demand and supply reduction policies in order to find effective solutions to various aspects of the world drug problem

  • CND Resolution 58/9 (2015)
    Promoting the role of drug analysis laboratories worldwide and reaffirming the importance of the quality of the analysis and results of such laboratories

  • CND Resolution 58/10 (2015)
    Promoting the use of the international electronic import and export authorization system for licit international trade in narcotic drugs and psychotropic substances

  • CND Resolution 58/11 (2015)
    Promoting international cooperation in responding to new psychoactive substances and amphetamine-type stimulants, including methamphetamine

  • CND Decision 58/1 (2015)
    Inclusion of mephedrone (4-methylmethcathinone) in Schedule II of the Convention on Psychotropic Substances of 1971

  • CND Decision 58/2 (2015)
    Review of ketamine

  • CND Decision 58/3 (2015)
    Inclusion of AH-7921 in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

  • CND Decision 58/4 (2015)
    Review of gamma-butyrolactone (GBL)

  • CND Decision 58/5 (2015)
    Review of 1,4-butanediol

  • CND Decision 58/6 (2015)
    Inclusion of 25B-NBOMe (2C-B-NBOMe) in Schedule I of the Convention on Psychotropic Substances of 1971

  • CND Decision 58/7 (2015)
    Inclusion of 25C-NBOMe (2C-C-NBOMe) in Schedule I of the Convention on Psychotropic Substances of 1971

  • CND Decision 58/8 (2015)
    Inclusion of 25I-NBOMe (2C-I-NBOMe) in Schedule I of the Convention on Psychotropic Substances of 1971

  • CND Decision 58/9 (2015)
    Inclusion of N-benzylpiperazine (BZP) in Schedule II of the Convention on Psychotropic Substances of 1971

  • CND Decision 58/10 (2015)
    Inclusion of JWH-018 in Schedule II of the Convention on Psychotropic Substances of 1971

  • CND Decision 58/11 (2015)
    Inclusion of AM-2201 in Schedule II of the Convention on Psychotropic Substances of 1971

  • CND Decision 58/12 (2015)
    Inclusion of 3,4-methylenedioxypyrovalerone (MDPV) in Schedule II of the Convention on Psychotropic Substances of 1971

  • CND Decision 58/13 (2015)
    Inclusion of methylone ( beta-keto-MDMA) in Schedule II of the Convention on Psychotropic Substances of 1971

  • GA Resolution A/RES/69/201 (2014)
    International cooperation against the world drug problem

  • CND Resolution 57/9 (2014)
    Enhancing international cooperation in the identification and reporting of new psychoactive substances and incidents involving such substances

  • CND Resolution 57/10 (2014)
    Preventing the diversion of ketamine from legal sources while ensuring its availability for medical use

  • CND Resolution 57/11 (2014)  
    Strengthening and expanding international cooperation to counter the threats posed by illicit production and manufacturing, trafficking and abuse of drugs in the Greater Mekong subregion

  • CND Decision 57/1 (2014)  
    Inclusion of alpha-phenylacetoacetonitrile and its optical isomers in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988

  • GA Resolution A/RES/68/197 (2013)
    International cooperation against the world drug problem

  • CND Resolution 56/4 (2013)
    Enhancing international cooperation in the identification and reporting of new psychoactive substances

  • CND Resolution 56/5 (2013)
    Promoting the sharing of expertise in and knowledge on forensic drug profiling

  • CND Resolution 56/7 (2013)
    Promoting the development and use of the international electronic import and export authorization system for licit international trade in narcotic drugs and psychotropic substances

  • CND Resolution 56/8 (2013)
    Promoting initiatives for the safe, secure and appropriate return for disposal of prescription drugs, in particular those containing narcotic drugs and psychotropic substances under international control

  • CND Resolution 56/10 (2013)
    Tools to improve data collection to monitor and evaluate the implementation of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem

  • CND Resolution 56/13 (2013)
    Precursors: raising awareness on the diversion in international trade of non-scheduled substances for use as alternatives to scheduled substances in the illicit manufacture of narcotic drugs and psychotropic substances

  • CND Resolution 56/16 (2013)
    Enhancing international cooperation to strengthen efforts in West Africa to counter illicit drug trafficking

  • CND Decision 56/1 (2013)
    Transfer of gamma-hydroxybutyric acid from Schedule IV to Schedule II of the Convention on Psychotropic Substances of 1971

  • GA Resolution 67/193 (2012)
    International cooperation against the world drug problem

  • CND Resolution 55/1 (2012)
    Promoting international cooperation in responding to the challenges posed by new psychoactive substances

  • CND Resolution 55/6 (2012)
    Developing an international electronic import and export authorization system for licit trade in narcotic drugs and psychotropic substances

  • CND Resolution 55/10 (2012)
    Promoting evidence-based drug prevention strategies and policies

  • GA Resolution 66/183 (2011)
    International cooperation against the world drug problem

  • CND Resolution 54/3 (2011)
    Ensuring the availability of reference and test samples of controlled substances at drug testing laboratories for scientific purposes

  • CND Resolution 54/6 (2011)
    Promoting adequate availability of internationally controlled narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion and abuse

  • CND Resolution 54/8 (2011)
    Strengthening international cooperation and regulatory and institutional frameworks for the control of precursor chemicals used in the illicit manufacture of synthetic drugs

  • CND Resolution 54/9 (2011)
    Improving quality and building monitoring capacity for the collection, reporting and analysis of data on the world drug problem and policy responses to it

  • GA A/RES/65/233 (2010)
    International cooperation against the world drug problem

  • CND Resolution 53/4 (2010)
    Promoting adequate availability of internationally controlled licit drugs for medical and scientific purposes while preventing their diversion and abuse

  • CND Resolution 53/7 (2010)
    International cooperation in countering the covert administration of psychoactive substances related to sexual assault and other criminal acts

  • CND Resolution 53/8 (2010)
    Strengthening international cooperation in countering the world drug problem focusing on illicit drug trafficking and related offences

  • CND Resolution 53/11 (2010)
    Promoting the sharing of information on the potential abuse of and trafficking in synthetic cannabinoid receptor agonists

  • CND Resolution 53/15 (2010)
    Strengthening international cooperation and regulatory and institutional frameworks for the control of substances frequently used in the manufacture of narcotic drugs and psychotropic substances

  • CND Decision 53/1 (2010)
    Transfer of phenylacetic acid from Table II to Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988

    For more information, please see https://www.unodc.org/unodc/en/commissions/CND/Resolutions_Decisions/Resolutions-Decisions_2010-2019.html